Nothing Special   »   [go: up one dir, main page]

CY1114765T1 - Activation of ACE2 for the treatment of heart, lung and kidney disease and hypertension - Google Patents

Activation of ACE2 for the treatment of heart, lung and kidney disease and hypertension

Info

Publication number
CY1114765T1
CY1114765T1 CY20141100043T CY141100043T CY1114765T1 CY 1114765 T1 CY1114765 T1 CY 1114765T1 CY 20141100043 T CY20141100043 T CY 20141100043T CY 141100043 T CY141100043 T CY 141100043T CY 1114765 T1 CY1114765 T1 CY 1114765T1
Authority
CY
Cyprus
Prior art keywords
ace2
hypertension
lung
heart
activation
Prior art date
Application number
CY20141100043T
Other languages
Greek (el)
Inventor
Josef Penninger
Michael A Crackower
Original Assignee
Apeiron Biologics Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10178474.2A external-priority patent/EP2332582B1/en
Application filed by Apeiron Biologics Ag filed Critical Apeiron Biologics Ag
Publication of CY1114765T1 publication Critical patent/CY1114765T1/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Η εφεύρεση σχετίζεται με μια τυποποιημένη συσκευασία εύρεσης γονοτύπου ACE2 που περιέχει έναν παράγοντα ανίχνευσης για ανίχνευση της παρουσίας ενός ACE2 πολυμορφισμού σε ένα δείγμα νουκλεϊνικού οξέος που προέρχεται από ζώο, κατά προτίμηση άνθρωπο.The invention relates to a standard ACE2 genotype-finding kit containing a detection agent for detecting the presence of an ACE2 polymorphism in a sample of an animal derived human, preferably a nucleic acid.

CY20141100043T 2002-06-19 2014-01-17 Activation of ACE2 for the treatment of heart, lung and kidney disease and hypertension CY1114765T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38970902A 2002-06-19 2002-06-19
EP10178474.2A EP2332582B1 (en) 2002-06-19 2003-06-19 ACE2 activation for treatment of heart, lung and kidney disease and hypertension

Publications (1)

Publication Number Publication Date
CY1114765T1 true CY1114765T1 (en) 2016-12-14

Family

ID=58464000

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100043T CY1114765T1 (en) 2002-06-19 2014-01-17 Activation of ACE2 for the treatment of heart, lung and kidney disease and hypertension

Country Status (1)

Country Link
CY (1) CY1114765T1 (en)

Similar Documents

Publication Publication Date Title
DK1515752T3 (en) ACE2 activation for the treatment of heart, lung and kidney diseases and hypertension
CY1105322T1 (en) METHODS AND COMPOSITIONS FOR THE DETECTION OF PATHOLOGICAL EVENTS
DE69938662D1 (en) TRACE DETECTION OF ANALYTES BY ARTIFICIAL OLFAKTOMETRY
CY1112525T1 (en) IMPROVED BEAMING METHODS
CY1108182T1 (en) MEASURES FOR DETERMINING THE PATHOLOGICAL TRANSFORMATION OF THE APP PROTEIN AND ITS APPLICATIONS
DK1421215T3 (en) Methods for evaluating pathological conditions using extracellular RNA
ATE480550T1 (en) HYBRIDIZATION CHAIN REACTION
MX336070B (en) Glyphosate tolerant alfalfa events and methods for detection thereof.
DE60042695D1 (en) METHOD FOR DETECTING DISEASES
ATE531820T1 (en) HEALTH CONDITION TEST
CY1105025T1 (en) LEPTIN ANALYSIS BASED ON ANG-2 EXPRESSION DETECTION
DK1198589T3 (en) Tenascin-C nucleic acid ligands
CY1112423T1 (en) ANTI-USE MICROPROCESSOR'S ANALYTICAL DEVICE
BR0314155A (en) Methods to Diagnose Cervical Cancer
CY1105566T1 (en) QUANTITATIVE DIAGNOSTIC ANALYSIS OF PREDISPOSITION TO HYPERTENSION
EP1680666A4 (en) ANTI-THERAPEUTIC HUMAN ANTIBODY DETECTION
MXPA05014220A (en) Genes regulated in ovarian cancer as prognostic and therapeutic targets.
ATE417545T1 (en) CATHETER HEAD
ATE449323T1 (en) REAGENTS AND METHODS USED FOR DETECTING BREAST DISEASES
WO2007060647A3 (en) A method for detecting or monitoring sepsis by analysing cytokine mrna expression levels
CY1114765T1 (en) Activation of ACE2 for the treatment of heart, lung and kidney disease and hypertension
EP1613204A4 (en) EVALUATION OF NEURONAL LESIONS FROM BLOOD SAMPLES
DE60144027D1 (en) 5T4 RNA IN PLASMA AND SERUM AS A MARKER FOR NEOPLASTIC ILLNESSES
DE60045932D1 (en) HIV-1 sequence amplification for recognition of sequences related to drug resistance mutations
DE50113417D1 (en) CELL BINDING NUCLEIC ACID MOLECULES (APTAMERE)